Clear answers to the questions international patients ask most about CAR-T therapy in China.
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an immunotherapy that reprograms a patient's own T cells to recognize and attack cancer cells. The cells are collected, genetically engineered, expanded, and infused back as a single dose — sometimes called a "living drug."
Approved uses are mainly in blood cancers: B-cell acute lymphoblastic leukemia (CD19), lymphomas such as diffuse large B-cell lymphoma (CD19), and multiple myeloma (BCMA). Solid-tumor CAR-T is largely still in clinical trials rather than standard approval.
Yes. Several NMPA-approved CAR-T products are used in Chinese hospitals that accept international patients. After a record review, our specialists determine eligibility and the most suitable product and hospital.
List prices for CAR-T in China are generally substantially lower than in the US or Europe, and the total treatment episode is often a fraction of Western pricing. We provide a transparent estimate before you travel; exact costs depend on the product, disease and hospital.
The two most important, manageable side effects are cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity (ICANS). Leading CAR-T centers in China have dedicated protocols and intensive-care backup to monitor and treat these promptly.
Absolutely. We offer record review and video consultations with hematology specialists so you can understand your eligibility and plan before committing to travel.
From apheresis collection to infusion, manufacturing typically takes 2–4 weeks. Including evaluation, infusion and required monitoring, the on-the-ground episode in China commonly spans several weeks. A personalized timeline is provided before you travel.
Most patients use a medical or humanitarian (S2) visa. We provide the medical invitation letter and supporting documents needed for your application.
We coordinate structured remote follow-up and share your complete medical record with your home-country physician so continuity of care is maintained.
No. Professional medical interpreters accompany you at consultations, procedures and ward rounds, and your discharge summary is provided in your language.